Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,000 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $356.02 | 16 | $0 (2024) |
| PFIZER INC. | $319.26 | 26 | $0 (2024) |
| ABBVIE INC. | $233.02 | 12 | $0 (2024) |
| Novo Nordisk Inc | $169.36 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $148.49 | 11 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $119.62 | 2 | $0 (2024) |
| Amgen Inc. | $109.98 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $70.31 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $58.00 | 4 | $0 (2023) |
| Lilly USA, LLC | $47.53 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $727.04 | 35 | AstraZeneca Pharmaceuticals LP ($153.67) |
| 2023 | $764.32 | 51 | AstraZeneca Pharmaceuticals LP ($151.99) |
| 2022 | $438.85 | 24 | Janssen Pharmaceuticals, Inc ($70.31) |
| 2021 | $69.60 | 5 | Lilly USA, LLC ($14.96) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Biological | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.85 | General |
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PAIN | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Gastroenterology | ||||||
| 09/10/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $50.99 | General |
| Category: GI | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Biological | ||||||
| 07/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: PAIN | ||||||
| 07/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PAIN | ||||||
| 05/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: PAIN | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.81 | General |
| 05/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neuromodulation | ||||||
| 05/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: PAIN | ||||||
| 04/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,002 | 3,509 | $340,157 | $130,973 |
| 2022 | 23 | 849 | 1,239 | $177,504 | $75,400 |
| 2021 | 7 | 174 | 212 | $30,437 | $14,267 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 1,800 | $111,300 | $33,509 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 254 | $52,578 | $21,569 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 273 | $40,131 | $16,763 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 81 | $22,842 | $10,201 | 44.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 37 | 117 | $20,709 | $8,533 | 41.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $16,209 | $7,897 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $8,536 | $5,254 | 61.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 25 | 25 | $7,200 | $3,814 | 53.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 51 | $3,810 | $3,658 | 96.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 33 | 75 | $9,675 | $3,443 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 145 | 324 | $4,536 | $2,700 | 59.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,002 | $2,679 | 38.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 15 | 16 | $5,088 | $2,157 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,798 | $2,038 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 53 | $1,537 | $1,504 | 97.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 23 | 25 | $3,375 | $1,257 | 37.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 23 | $5,439 | $978.10 | 18.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 11 | 12 | $2,640 | $928.42 | 35.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 75 | $5,025 | $780.75 | 15.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $708.40 | $694.12 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 25 | $3,275 | $251.76 | 7.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 14 | $574.00 | $227.08 | 39.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 108 | $756.00 | $78.08 | 10.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 18 | $414.00 | $59.19 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 229 | $47,403 | $20,567 | 43.4% |
About Dr. Alan Spanel, MD
Dr. Alan Spanel, MD is a Internal Medicine healthcare provider based in Norfolk, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1023508892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Spanel, MD has received a total of $2,000 in payments from pharmaceutical and medical device companies, with $727.04 received in 2024. These payments were reported across 115 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,000).
As a Medicare-enrolled provider, Spanel has provided services to 2,025 Medicare beneficiaries, totaling 4,960 services with total Medicare billing of $220,640. Data is available for 3 years (2021–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Norfolk, NE
- Active Since 05/16/2018
- Last Updated 08/18/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1023508892
Products in Payments
- NURTEC ODT (Drug) $205.60
- ELIQUIS (Drug) $188.15
- AIRSUPRA (Drug) $104.38
- QULIPTA (Drug) $101.54
- XIGDUO (Drug) $96.35
- FARXIGA (Drug) $89.74
- Ozempic (Drug) $78.74
- TRELEGY ELLIPTA (Drug) $75.94
- NUCALA (Biological) $72.55
- XARELTO (Drug) $70.31
- ZENPEP (Drug) $68.63
- Rybelsus (Drug) $65.64
- VRAYLAR (Drug) $62.88
- EVENITY (Biological) $59.76
- VOWST (Biological) $50.99
- UBRELVY (Drug) $48.77
- Veozah (Drug) $43.33
- GVOKE HYPOPEN (Drug) $31.70
- JARDIANCE (Drug) $31.10
- XIFAXAN (Drug) $30.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Norfolk
Dr. Paul Marik, M.d, M.D
Internal Medicine — Payments: $52,088
Dr. Olusegun Olusesi, M.d, M.D
Internal Medicine — Payments: $45,492
Charles Lovell, Md, MD
Internal Medicine — Payments: $37,192
Prashant Barakoti, Md, MD
Internal Medicine — Payments: $17,975
Albert Cheung, M.d, M.D
Internal Medicine — Payments: $17,320
Dr. Charles Harper, Md, MD
Internal Medicine — Payments: $16,151